Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tylenol Arthritis Pain Name/Claims Change To Be Reflected In Future Ads

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Health will alter advertising for Tylenol Arthritis Pain in 2001 to incorporate a revised indication for "pain treatment" in line with a recent FDA decision on a citizen petition submitted by the Aspirin Foundation of America.

You may also be interested in...



Tylenol 8 Hour Advertising Campaign Slated For Late Spring Launch

Advertising for McNeil Consumer & Specialty Pharmaceuticals' new Tylenol 8 Hour will begin in May and use "all available media," including TV, print and radio, according to the firm

Tylenol 8 Hour Advertising Campaign Slated For Late Spring Launch

Advertising for McNeil Consumer & Specialty Pharmaceuticals' new Tylenol 8 Hour will begin in May and use "all available media," including TV, print and radio, according to the firm

Tylenol 8 Hour Advertising Campaign Slated For Late Spring Launch

Advertising for McNeil Consumer & Specialty Pharmaceuticals' new Tylenol 8 Hour will begin in May and use "all available media," including TV, print and radio, according to the firm

Related Content

Topics

UsernamePublicRestriction

Register

PS091993

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel